Skip to main content
Log in

A de novo SPAST mutation leading to somatic mosaicism is associated with a later age at onset in HSP

  • Letter to the Editors
  • Published:
Neurogenetics Aims and scope Submit manuscript

Abstract

SPG4/SPAST, the gene-encoding spastin, is responsible for the most frequent form of autosomal dominant hereditary spastic paraplegia (HSP). SPG4-HSP is a heterogeneous disorder characterized by both interfamilial and intrafamilial variation, especially regarding the severity and the age at onset. In this study, we investigated the origin of the mutation and the factors involved in intra-familial heterogeneity in a family with a SPG4 mutation. We demonstrated that the mutation occurred de novo and show evidence of somatic mosaicism in the grandfather, who was the only affected member of six siblings. His disease began at age 55, much later than in his daughter, who had onset at age 18, and his grandson, in whom onset was at age 5. These observations indicate that de novo mutations can occur in SPG4, and that somatic mosaicism might account for intra-familial variation in SPG4-linked HSP.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Fink JK, Rainier S (2004) Hereditary spastic paraplegia: spastin phenotype and function. Arch Neurol 61:830–833

    Article  PubMed  Google Scholar 

  2. Fonknechten N, Mavel D, Byrne P, Davoine CS, Cruaud C, Bonsch D, Samson D, Coutinho P, Hutchinson M, McMonagle P, Burgunder JM, Tartaglione A, Heinzlef O, Feki I, Deufel T, Parfrey N, Brice A, Fontaine B, Prud’homme JF, Weissenbach J, Durr A, Hazan J (2000) Spectrum of SPG4 mutations in autosomal dominant spastic paraplegia. Hum Mol Genet 9:637–644

    Article  PubMed  CAS  Google Scholar 

  3. Depienne C, Tallaksen C, Lephay JY, Bricka B, Poea-Guyon S, Fontaine B, Labauge P, Brice A, Durr A (2006) Spastin mutations are frequent in sporadic spastic paraparesis and their spectrum is different from that observed in familial cases. J Med Genet 43:259–265

    Article  PubMed  CAS  Google Scholar 

  4. Glaab WE, Skopek TR (1999) A novel assay for allelic discrimination that combines the fluorogenic 5′ nuclease polymerase chain reaction (TaqMan) and mismatch amplification mutation assay. Mutat Res 430:1–12

    PubMed  CAS  Google Scholar 

  5. Svenson IK, Ashley-Koch AE, Gaskell PC, Riney TJ, Cumming WJ, Kingston HM, Hogan EL, Boustany RM, Vance JM, Nance MA, Pericak-Vance MA, Marchuk DA (2001) Identification and expression analysis of spastin gene mutations in hereditary spastic paraplegia. Am J Hum Genet 68:1077–1085

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgment

The authors thank the family for its participation and the DNA and cell bank of IFR70 for DNA extraction. This work was supported by the VERUM foundation and the Programme Hospitalier de Recherche Clinique AP-HP (n°AOM03059, to AD).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alexis Brice.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Depienne, C., Fedirko, E., Faucheux, JM. et al. A de novo SPAST mutation leading to somatic mosaicism is associated with a later age at onset in HSP. Neurogenetics 8, 231–233 (2007). https://doi.org/10.1007/s10048-007-0090-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10048-007-0090-4

Keywords

Navigation